Harbour BioMed
0 followers
02142
Performance
About Harbour BioMed
Harbour BioMed is a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibody therapeutics, particularly in oncology and immunology. The company utilizes proprietary technology platforms, such as Harbour Mice®, to generate fully human monoclonal antibodies and advanced immune cell engagers (HBICE®). Harbour BioMed enhances its R&D capabilities through collaborations and strategic acquisitions to build a robust pipeline of therapeutic antibodies.
Recent News
No recent news for this company.